Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited is a Private limited company (Ltd.) registered in Hong Kong under F0010234, and its current status with Companies Registry is active. Its registered address on file is Wan Chai, Hong Kong. 5 shareholders are on record for Sino Biopharmaceutical Limited, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Companies Registry and was last updated on 23 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of Sino Biopharmaceutical Limited
Five shareholders are currently on record for Sino Biopharmaceutical Limited, held on the Annual Return (NAR1), filed under the Companies Ordinance (Cap. 622). The largest of these is iShares Trust-iShares MSCI China ETF, holding 5.2% — the largest recorded stake — followed by Rhumbline Advisers at 0%; the remaining 3 shareholders shown hold smaller stakes. 2 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 3 are recorded as direct individual holders, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Data availability
The register reports 7 shareholders in total, though only the top 5 by holding are shown in this view.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| iShares Trust-iShares MSCI China ETF | 5.2% | Companies Registry | |
| Rhumbline Advisers | 0% | Companies Registry | |
| -Unified Series Trust-FIIG ESG Stock Fd | 0% | Companies Registry | |
| Unified Series Trust-FIIG ESG Stock Plan for Retirement | 0% | Companies Registry | |
| Unified Series Trust-FIIG Stock Fund for Retirement | 0% | Companies Registry |
Group Structure
Group structure of Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited sits 1 level below its ultimate parent, Sino Biopharmaceutical Limited, registered in Cayman Islands. 11 subsidiaries are recorded beneath it, across 2 jurisdictions. The full chain up to Sino Biopharmaceutical Limited is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Sino Biopharmaceutical Limited's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- CHIA TAI RESOURCES LIMITED (Hong Kong)
- FINE ENTERPRISE INVESTMENT LIMITED (Hong Kong)
- Zhongsheng Capital Investment Limited (Hong Kong)
- CHIA TAI WING FUK LIMITED (Hong Kong)
- Sino Biopharmaceutical (Beijing) Limited (Hong Kong)
- Talent Forward Limited (Hong Kong)
- X-Lab Innovation Limited (Hong Kong)
- LUCKY SYMBOL HOLDINGS LIMITED (Hong Kong)
- CHINA EASTERN DEVELOPMENT LIMITED (Hong Kong)
- Chia Tai Pharmaceutical (Lianyungang) Company Limited (Hong Kong)
Data availability
Those 11 subsidiaries span Hong Kong, China jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Four of the 11 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Sino Biopharmaceutical Limited
Cayman Islands
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Sino Biopharmaceutical Limited?
Five shareholders are currently on record for Sino Biopharmaceutical Limited, held on the Annual Return (NAR1), filed under the Companies Ordinance (Cap. 622). The largest of these is iShares Trust-iShares MSCI China ETF, holding 5.2% — the largest recorded stake — followed by Rhumbline Advisers at 0%; the remaining 3 shareholders shown hold smaller stakes. 2 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 3 are recorded as direct individual holders, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is Sino Biopharmaceutical Limited's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for Sino Biopharmaceutical Limited is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does Sino Biopharmaceutical Limited have on record?
5 shareholders are shown on record for Sino Biopharmaceutical Limited. The register reports 7 in total; only the top 5 by holding are shown here.
What is Sino Biopharmaceutical Limited's company registration number?
Sino Biopharmaceutical Limited's registration number is F0010234, filed with Companies Registry in Hong Kong. Its current status on the register is active.
Is Sino Biopharmaceutical Limited still an active company?
Sino Biopharmaceutical Limited's status on Companies Registry is listed as active.
What is Sino Biopharmaceutical Limited's registered address?
The registered address on file for Sino Biopharmaceutical Limited is Wan Chai, Hong Kong.
What legal structure is Sino Biopharmaceutical Limited registered as?
Sino Biopharmaceutical Limited is registered as a Private limited company (Ltd.) in Hong Kong.
Does Sino Biopharmaceutical Limited have a parent company or subsidiaries?
Sino Biopharmaceutical Limited sits 1 level below its ultimate parent, Sino Biopharmaceutical Limited, registered in Cayman Islands. 11 subsidiaries are recorded beneath it, across 2 jurisdictions. Those 11 subsidiaries span Hong Kong, China jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Four of the 11 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Sino Biopharmaceutical Limited's ownership over time?
This profile reflects a point-in-time snapshot from Companies Registry. Zavia's monitoring API can track changes to Sino Biopharmaceutical Limited's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Sino Biopharmaceutical Limited's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Hong Kong, so records like Sino Biopharmaceutical Limited's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies Registry and was last synced on 23 September 2026.